Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gregory Finucane"'
Autor:
Gregory Finucane, Arnold Bok, Michelle M. Lockhart, Mark P. Simpson, Adele McMahon, Lorraine Macdonald, Andrew Smith, Barry Snow, Kenneth Martin Taylor, Chris Frampton, Bb Janice Lam, Eoin Mulroy, Patrick Schweder, Benson S Chen
Publikováno v:
Parkinsonism & Related Disorders. 61:88-93
Introduction Regenerative therapies in Parkinson's disease aim to slow neurodegeneration and re-establish damaged neuronal circuitry. Neurotrophins are potent endogenous regulators of neuronal survival, development and regeneration. They represent an
Autor:
Adele McMahon, Chris Frampton, Eoin Mulroy, Benson S Chen, Arnold Bok, Gregory Finucane, Kenneth Martin Taylor, Lorraine Macdonald, Michelle M. Lockhart, Mark Simpson, Patrick Schweder, Barry Snow, B.B. Janice Lam, Andrew Smith
Publikováno v:
Parkinsonismrelated disorders. 82
Introduction In 2019, we published the results of a Phase IIb randomized controlled trial of putaminal encapsulated porcine choroid plexus cell (termed NTCELL®) administration in patients with Parkinson's disease. This study failed to meet its prima
Autor:
Barry, Snow, Eoin, Mulroy, Arnold, Bok, Mark, Simpson, Andrew, Smith, Kenneth, Taylor, Michelle, Lockhart, Bb Janice, Lam, Christopher, Frampton, Patrick, Schweder, Benson, Chen, Gregory, Finucane, Adele, McMahon, Lorraine, Macdonald
Publikováno v:
Parkinsonismrelated disorders. 61
Regenerative therapies in Parkinson's disease aim to slow neurodegeneration and re-establish damaged neuronal circuitry. Neurotrophins are potent endogenous regulators of neuronal survival, development and regeneration. They represent an attractive r
Autor:
Ailsa L. McGregor, Robert R. Kydd, Jo Dysart, Malcolm D. Tingle, Bruce R. Russell, Gregory Finucane
Publikováno v:
Neuropsychiatric Disease and Treatment
Ailsa L McGregor,1,2 Jo Dysart,3 Malcolm D Tingle,4 Bruce R Russell,1,2 Rob R Kydd,5 Gregory Finucane2 1New Zealand’s National School of Pharmacy, Division of Health Sciences, University of Otago, Dunedin, New Zealand; 2Centre for Brain Research, U
Publikováno v:
Internal Medicine Journal. 42:e151-e156
Background: The American Academy of Neurology considers clozapine first line treatment for psychosis in Parkinson's disease (PD). In practice, patients are typically treated with quetiapine initially despite only level C evidence for use due to conce
Autor:
Gregory Finucane
Publikováno v:
Neuropsychiatry Case Studies ISBN: 9783319421889
GS is a 37-year-old female former clerical worker who had been treated for epilepsy since infancy with no significant periods of remission despite multiple trials of anticonvulsants including phenytoin, carbamazepine, sodium valproate, vigabatrin, ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bee02b4b5362a478c0b6bae62392e43
https://doi.org/10.1007/978-3-319-42190-2_24
https://doi.org/10.1007/978-3-319-42190-2_24
Publikováno v:
Journal of Huntington's disease. 1(1)
We aimed to determine if the appointment of a Huntington's disease (HD) nurse specialist has influenced inpatient admission rates and admission quality at Auckland Hospital. We collated HD inpatient admission data for the 32 months before and after h
Autor:
Ravi, Suppiah, Edward, Mee, Elizabeth B, Walker, Lynair, Roberts, Gregory, Finucane, Peter S, Bergin
Publikováno v:
The New Zealand medical journal. 122(1305)
To analyse the long-term outcome of patients who underwent temporal lobe resection for intractable temporal lobe epilepsy at Auckland Hospital.We performed a retrospective analysis of 176 patients who underwent temporal lobe resection at Auckland Hos